The Incidence of Thrombotic Manifestations in AT III Abnormalities

• References

• 1 Bauer KA, Ashenfurst JB, Chediak J, Rosemberg RD. Antithrombin “Chicago”: a functionally abnormal molecule with increased heparin affinity causing familial thrombophilia. Blood 1983; 62: 1242-1250
• 2 Chasse JF, Esnard F, Guitton JD, Monray H, Perigois F, Fauconneau G, Gauthier F. An abnormal plasma antithrombin with no apparent affinity for heparin. Thromb Res 1984; 34: 297-302
• 3 Fischer AM, Gazengel C, Dautzenberg MD, Benhammo J, Beguin S, Vergoz D. A new case of abnormal antithrombin III (AT III): biological characteristics and thromboembolic accidents management. Thromb Haemostas 1983; 50: 358 (Abstr)
• 4 Fischer AM, Cornu P, Sternberg C, Meriane F, Chafa O, Dautzenberg MD, Beguin S, Desnos M. Antithrombin III Alger: a new homozygous AT III variant. Thromb Haemostas 1986; 55: 218-221
• 5 Girolami A, Pengo V, Patrassi GM, Cappellato G, Vianello C, Cartei L. Antithrombin III Padua: a “new” congenital antithrombin III abnormality with normal or near normal activity, normal antigen, abnormal migration and no thrombotic disease. Folia Haematol 1983; 110: 98-111
• 6 Girolami A, Cappellato G, Vicarioto MA, Vergolani A, Traverso R. Behavior of antithrombin III abnormalities in the crossed immunoelectrophoretic system. Folia Haematol 1985; 112: 159-164
• 7 Girolami A, Fabris F, Cappellato G, Sainati L, Boeri G. Antithrombin III Padua₂: a new congenital abnormality with defective heparin co-factor activities but no thrombotic disease. Blut 1983; 47: 93-103
• 8 Girolami A, Marafioti F, Rubestello M, Vicarioto MA, Cappellato G, Maruccolo M. Antithrombin III Trento: a new congenital AT III abnormality with a peculiar crossed immunoelectrophoretic pattern in the absence of heparin. Acta Haematol 1984; 72: 73-82
• 9 Girolami A, Cappellato G, Vicarioto MA, Casonato S, Marafioti F. Associated von Willebrand’s disease as a possible cause of lack of thrombosis in AT III (AT III Trento). Blut 1986; 52: 29-33
• 10 Howarth DJ, Samson D, Stirling Y, Seghatchian MJ. Antithrombin III “Northwick Park”: a variant antithrombin with normal affinity for heparin but reduced heparin co-factor activity. Thromb Haemostas 1985; 53: 314-319
• 11 Koide T, Takahashi K, Odami S, Ono T, Sakuragawa N. Isolation and characterization of a hereditary abnormal antithrombin III “antithrombin III Toyama”. Thromb Res 1983; 31: 319-328
• 12 Nagy I, Losonczy H. Three types of hereditary AT III deficiency. Thromb Haemostas 1979; 42: 187 (Abstr)
• 13 Penner JA, Hassouna H, Hunter MJ, Chockley M. A clinically silent antithrombin III defect in an Ann Arbor family. Thromb Haemostas 1979; 42: 186 (Abstr)
• 14 Tran TH, Bounameaux H, Bondeli C, Honkanen H, Marbet GA, Duckert F. Purification and partial characterization of a hereditary abnormal antithrombin III fraction of a patient with recurrent thrombophlebitis. Thromb Haemostas 1980; 44: 87-91
• 15 Wolf M, Boyer C, Lavergne JM, Larrieu MJ. A new familial variant of Antithrombin III: Antithrombin III Paris. Br J Haematol 1982; 51: 285-295